Insiders · Profile

COOPER GLENN L MD

Director at REPLIGEN · See Remarks at Fortress Biotech. Filing since 9 Nov 2009. CIK 0001046351

Company
Date
Role
Action
Shares
Amount
Of holding
23 May 2019
Director
Sold, plan not stated
5,000
$334.71K
12.3%
30 Nov 2012
See Remarks
Bought
3,811
$15.32K
9.5%
21 Sep 2012
Director
Bought
10,000
$60.87K
62.4%
22 Jun 2012
See Remarks
Bought
10,000
$52.97K
33.3%
9 Nov 2009
Director
Bought
5,000
$24.90K
opened
5 decisions on file.